BioCorRx Inc. | Business Contracts

Form of Indemnification Agreement (Filed With SEC on January 23, 2023)

Form of Murthy Director Agreement (Filed With SEC on January 23, 2023)

Form of Exchange Agreement entered into with Messrs. Galligan and Lucido in Sept 2022 (Filed With SEC on November 14, 2022)

BioCorRx Inc. 2022 Omnibus Securities and Incentive Plan (Filed With SEC on April 28, 2022)

Inter-Company License Agreement by and between BioCorRx Inc. and BioCorRx Pharmaceuticals, Inc., effective September 22, 2021 (Filed With SEC on March 31, 2022)

Second Amendment To Lease, dated July 11, 2019, by and between BioCorRx Inc. and Axis Campus Owner, LLC (Filed With SEC on November 14, 2019)

Form of Subscription Agreement by and between BioCorRx Inc. and the Purchaser initially effective May 6, 2022 (Filed With SEC on May 12, 2022)

Form of Warrant (Filed With SEC on May 12, 2022)

Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 31, 2022)

Form of Subscription Agreement by and between BioCorRx Inc. and each of the Lucido and Galligan Trusts initially effective January 12, 2022 (Filed With SEC on January 19, 2022)

Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 31, 2021)

Form of Subscription Agreement by and between BioCorRx Inc. and each of the Lucido and Galligan Trusts entered into on February 23, 2021 (Filed With SEC on February 26, 2021)

Form of Galligan Director Agreement (Filed With SEC on February 22, 2021)

Lock-Up Agreement, dated September 30, 2019 by and between BioCorRx Inc., and BICX Holding Company LLC (Filed With SEC on October 4, 2019)

Conversion Agreement, dated September 30, 2019 by and between BioCorRx Inc., and BICX Holding Company LLC (Filed With SEC on October 4, 2019)

Statement of Work 2 by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 30, 2019 (Filed With SEC on June 14, 2019)

Statement of Work 1 by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 30, 2019 (Filed With SEC on June 14, 2019)

Master Services Agreement by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 24, 2019 (Filed With SEC on June 14, 2019)

Subscription and Royalty Agreement by and between BioCorRx Inc. and J and R Galligan Revocable Trust (Filed With SEC on April 3, 2019)

Subscription and Royalty Agreement by and between BioCorRx Inc. and Louis and Carolyn Lucido CRT LLC (Filed With SEC on April 3, 2019)

Subscription Agreement dated February 22, 2019 (Filed With SEC on March 8, 2019)

Form of Director Agreement (Filed With SEC on March 7, 2019)

Form of Director Agreement (Filed With SEC on February 22, 2019)

BioCorRx Inc. (23)